N-myristoyltransferase: A potential novel diagnostic marker for colon cancer
Open Access
- 16 November 2007
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 5 (1), 58
- https://doi.org/10.1186/1479-5876-5-58
Abstract
Background Colon cancer is the second leading cause of cancer deaths in the western world. If detected early, colorectal cancer is one of the most treatable forms of cancer. Unfortunately, very few people are screened. N-myristoyltransferase (NMT) catalyzes myristoylation of various proteins including oncoproteins. We have demonstrated earlier the alteration of NMT activity during the progression of colorectal cancer and established NMT as a putative therapeutic target for cancer. Methods Peripheral blood samples and bone marrow were collected from the colon cancer patients and azoxymethane induced colonic tumor rats and their controls respectively. NMT activity and expression was determined as reported earlier. Immunohistochemical studies were carried out using standard procedures. Results In this study we demonstrate for the first time altered expression and localization of NMT in the peripheral blood and bone marrow in colon cancer patients. Immunohistochemical analysis revealed weak to negative staining for NMT in peripheral blood mononuclear cells (PBMC) of controls, whereas strong positivity was observed in PBMC colon cancer patients. In addition, we observed that NMT was localized mostly in the nuclei of the bone marrow (BM) mononuclear cells of the colon cancer patients, whereas NMT remained cytoplasmic in the control bone marrow specimens. Conclusion The strikingly different NMT expression offers the basis of a potential adjunct investigative tool for screening or diagnosis of patients at risk for or suspected of having colon cancer. Furthermore, altered localization of NMT in BM of tumor bearing hosts may serve as an added investigative tool for the diagnostic purpose.Keywords
This publication has 10 references indexed in Scilit:
- Regulation of N-Myristoyltransferase by Novel Inhibitor ProteinsCell Biochemistry and Biophysics, 2005
- Epidermal Growth Factor Receptor, c-MET, β-Catenin, and p53 Expression as Prognostic Indicators in Stage II Colon CancerClinical Cancer Research, 2004
- Potent inhibitor of N-myristoylation: a novel molecular target for cancer.2003
- Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes’ B colorectal cancer patients: how much evidence is enough?Annals Of Oncology, 2003
- The Biology and Enzymology of ProteinN-MyristoylationPublished by Elsevier BV ,2001
- N-myristoyltransferaseMolecular and Cellular Biochemistry, 2000
- Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1999
- N-Myristoyltransferase Overexpression in Human Colorectal AdenocarcinomasExperimental Cell Research, 1997
- MyristoylationCellular Signalling, 1997
- Increased N-Myristoyltransferase Activity Observed in Rat and Human Colonic TumorsJNCI Journal of the National Cancer Institute, 1995